Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_2
1
14%
Ph phase_1
2
29%
Ph phase_4
1
14%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Withdrawn2
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

enrolling_by_invitation114%
withdrawn229%
unknown114%
completed343%

Recent Activity

0 active trials
Showing 5 of 7
enrolling_by_invitationphase_4

Imaging of Brain Amyloid Plaques in the Aging Population

NCT00950430
withdrawn

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA

NCT00373711
unknown

Validity of Mediastinal Blood Pool SUV Ratio

NCT05258045
completedphase_2

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

NCT03125629
withdrawnnot_applicable

Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography

NCT03266562
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT00950430Phase 4

Imaging of Brain Amyloid Plaques in the Aging Population

Enrolling By Invitation
NCT00373711

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA

Withdrawn
NCT05258045

Validity of Mediastinal Blood Pool SUV Ratio

Unknown
NCT03125629Phase 2

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Completed
NCT03266562Not Applicable

Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography

Withdrawn
NCT01623284Phase 1

PiB PET Scanning in Speech and Language Based Dementias

Completed
NCT01609335Phase 1

Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7